RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 78 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,613 | +18.2% | 59,688 | +15.4% | 0.00% | – |
| Q2 2023 | $386,311 | -34.7% | 51,715 | -41.7% | 0.00% | – |
| Q1 2023 | $591,362 | +8.1% | 88,660 | +24.9% | 0.00% | – |
| Q4 2022 | $547,201 | -11.5% | 70,973 | +22.2% | 0.00% | – |
| Q3 2022 | $618,000 | +18.2% | 58,070 | -9.7% | 0.00% | – |
| Q2 2022 | $523,000 | +11.0% | 64,318 | -2.3% | 0.00% | – |
| Q1 2022 | $471,000 | -62.2% | 65,799 | -9.6% | 0.00% | -100.0% |
| Q4 2021 | $1,247,000 | +223.9% | 72,801 | +334.3% | 0.00% | – |
| Q3 2021 | $385,000 | -19.6% | 16,762 | +27.7% | 0.00% | – |
| Q2 2021 | $479,000 | – | 13,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |